Metropolis Healthcare Limited is a leading diagnostics company in India by revenue that offers an inclusive range of clinical laboratory tests and profiles (Source: Frost & Sullivan). It offers a wide range of 3,480 clinical laboratory tests and 524 profiles that are classified across “routine”, “semi-specialized” and “specialized” tests. As on 31st March 2018, the company have 4,585 employees on its payroll.
Date of Incorporation: The Company was initially incorporated as “Dr V. K. Desai Hospital” as a partnership firm in January 1980. Subsequently, it was amended to “Metropolis Healthcare Limited” beginning as a public limited company on 23rd September 2009.
Promoters of the Company: Dr Sushil Kanubhai Shah, Ameera Sushil Shah and Metz Advisory LLP are the promoters of Metropolis Healthcare Limited.
Products and Services: It offers a range of clinical tests and profiling that are used for prediction, early detection, diagnostic screening, confirmation and monitoring of disease. It caters the customer through:
- Individual patients are served through Patient touch points, home collection service.
- Healthcare providers are served through pick-up points and ARC’s.
- Other Customers are served through clinical research, PPP and Laboratory in Hospital.
Customer Segments: Metropolis Healthcare Limited has its ARCs, clinical laboratories and patient touch points across India in states of Maharashtra, Gujarat, Andhra Pradesh, Rajasthan, Karnataka, Delhi, Bihar, West Bengal and several other states.
While it has also active presence outside India across Ghana, Kenya, Zambia, Mauritius and Sri Lanka. It has also ventured with third parties in Nepal, Nigeria, UAE and Oman.
Objects of the Offer: The main objectives of Metropolis Healthcare Limited are:
- Finance offer related to expenses.
- Monitoring Utilization of Funds.
- Offer for Sale by selling stakeholders.
For the year/period ended (in Rs. Millions)
Profit After Tax